Glial Glutamate Transporter (GLT-1) Role in Dependence in Male Morphine-Treated Rats
Journal Title: The 1st Annual Meeting of Georgian Center for Neuroscience Research - Year 2020, Vol 2, Issue 20
Abstract
Addiction as a neuropsychiatric disorder affects a large number of people and imposes a high economic burden on the community. Similar to other diseases, a proper understanding of the biological basis of addiction will lead to more effective therapies. Opiates are the oldest and most well-known group of drugs that are used clinically as analgesics. But they are also abused. The incidence of dependence limits the therapeutic use of these drugs. Glutamatergic system appears to have an important role in opioid dependency but the mechanism remains poorly understood. Here, we evaluated the role of hippocampal glial glutamate transporter (GLT-1) in morphine dependence in male treated rats. Morphine (10 mg/kg) was injected subcutaneously at an interval of 12 h for 9 days to make rats dependent. Withdrawal signs were evaluated after intraperitoneally administration of naloxone (1.5 mg/kg) for 20 minutes. Morphine withdrawal signs were also assessed in rats which were treated by ceftriaxone (0.5 µl, 0.5 mmol) microinjection in CA1 region of hippocampus before morphine injection. Our results showed that pretreatment with ceftriaxone in male morphine treated rats in comparison with those which didn’t receive ceftriaxone reduced some signs of morphine withdrawal syndrome such as activity, ptosis, freezing and head tremor (unpaired t-test, P<0.001, P<0.01). Based on the obtained results, the present study revealed that susceptibility of CA1 neurons to dependence was changed due to chronic use of morphine and this alteration in neuronal function is mediated partly by glial cells in hippocampal CA1 area.
Authors and Affiliations
Negin Saeedi, Narges Hosseinmardi, Mahyar Janahmadi
Keywords
Related Articles
- EP ID EP677949
- DOI 10.29088/GCNR-2020.40
- Views 196
- Downloads 0
The Role of Tamoxifen (A Selective Estrogen Receptor Modulator) on Neurological Score, Blood-Brain Barrier and Brain Edema after Traumatic Brain Injury in Male Rats: The Role of Matrix Metalloproteinase-9
Introduction: Tamoxifen is an oral medication which is used for the treatment of breast cancer, and it acts on an estrogen receptor for agonist or antagonistic activity (effects) due to its effects on the environment. T...
The Neuroprotective Effect of Ursolic Acid Associated with Inflammation Factors: IL-10, IL β after the Induction of Severe Traumatic Brain Injury in Rats
Introduction: Ursolic Acid (UA) is a Penta cyclic triterpene compound which Reduces cerebral edema and improves neurological deficits after TBI, leading to increased Nrf2 protein and increased expression of reductase-1...
Investigation the Effects of Orexins on Behavioral, Morphological and Electrophysiological Alterations Induced by the Kainic Acid Model of Temporal Lobe Epilepsy
Epilepsy is a chronic brain disease, which has a significant impact on the quality of life of up to 50 million people worldwide. The pathophysiology of disease is still not clear. Epilepsy is characterized by the appear...
The Comparison of Executive Functions in Addicts and Patients Under Buprenorphine Maintenance Treatment (BMT)
Introduction: Buprenorphine, a partial opioid agonist of the µ-receptor, is one of the most important developments in pharmacotherapy for opioid addiction. However, there are some clinical and empirical evidence for exe...
Contribution of Nitric Oxide in Initiation of Cortical Spreading Depression in Ischemic Stroke
Nitric oxide (NO), the most convincing gaseous signaling molecule in vertebrates, was increasingly recognized as one of the most versatile and unique molecules mediating such diverse physiological functions as the maint...